Literature DB >> 22575214

Epithelial to mesenchymal transition: new and old insights from the classical neural crest model.

Pablo H Strobl-Mazzulla1, Marianne E Bronner.   

Abstract

The epithelial-to-mesenchymal transition (EMT) is an important event converting compact and ordered epithelial cells into migratory mesenchymal cells. Given the molecular and cellular similarities between pathological and developmental EMTs, studying this event during neural crest development offers and excellent in vivo model for understanding the mechanisms underlying this process. Here, we review new and old insight into neural crest EMT in search of commonalities with cancer progression that might aid in the design of specific therapeutic prevention.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22575214      PMCID: PMC3435443          DOI: 10.1016/j.semcancer.2012.04.008

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  86 in total

1.  Expression of cell adhesion molecules during initiation and cessation of neural crest cell migration.

Authors:  T Akitaya; M Bronner-Fraser
Journal:  Dev Dyn       Date:  1992-05       Impact factor: 3.780

2.  Spatial and temporal expression pattern of N-cadherin cell adhesion molecules correlated with morphogenetic processes of chicken embryos.

Authors:  K Hatta; S Takagi; H Fujisawa; M Takeichi
Journal:  Dev Biol       Date:  1987-03       Impact factor: 3.582

3.  Ultrastructure of neural crest formation in the midbrain/rostral hindbrain and preotic hindbrain regions of the mouse embryo.

Authors:  D H Nichols
Journal:  Am J Anat       Date:  1987-06

Review 4.  The role of cell-cell and cell-matrix interactions in the morphogenesis of the neural crest.

Authors:  C A Erickson; R Perris
Journal:  Dev Biol       Date:  1993-09       Impact factor: 3.582

5.  Factors controlling the time of onset of the migration of neural crest cells in the fowl embryo.

Authors:  D Newgreen; I Gibbins
Journal:  Cell Tissue Res       Date:  1982       Impact factor: 5.249

6.  Multiple modes of activation of latent human fibroblast collagenase: evidence for the role of a Cys73 active-site zinc complex in latency and a "cysteine switch" mechanism for activation.

Authors:  E B Springman; E L Angleton; H Birkedal-Hansen; H E Van Wart
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

7.  Adhesion to extracellular materials by neural crest cells at the stage of initial migration.

Authors:  D F Newgreen
Journal:  Cell Tissue Res       Date:  1982       Impact factor: 5.249

8.  Tissue inhibitor of metalloproteinase (TIMP-2). A new member of the metalloproteinase inhibitor family.

Authors:  W G Stetler-Stevenson; H C Krutzsch; L A Liotta
Journal:  J Biol Chem       Date:  1989-10-15       Impact factor: 5.157

9.  An antibody to a receptor for fibronectin and laminin perturbs cranial neural crest development in vivo.

Authors:  M Bronner-Fraser
Journal:  Dev Biol       Date:  1986-10       Impact factor: 3.582

10.  Structure of the zebrafish snail1 gene and its expression in wild-type, spadetail and no tail mutant embryos.

Authors:  C Thisse; B Thisse; T F Schilling; J H Postlethwait
Journal:  Development       Date:  1993-12       Impact factor: 6.868

View more
  21 in total

1.  G-CSF Promotes Neuroblastoma Tumorigenicity and Metastasis via STAT3-Dependent Cancer Stem Cell Activation.

Authors:  Saurabh Agarwal; Anna Lakoma; Zaowen Chen; John Hicks; Leonid S Metelitsa; Eugene S Kim; Jason M Shohet
Journal:  Cancer Res       Date:  2015-04-23       Impact factor: 12.701

Review 2.  PleiotRHOpic: Rho pathways are essential for all stages of Neural Crest development.

Authors:  Philippe Fort; Eric Théveneau
Journal:  Small GTPases       Date:  2014-03-10

3.  DNA methyltransferase 3B regulates duration of neural crest production via repression of Sox10.

Authors:  Na Hu; Pablo H Strobl-Mazzulla; Marcos Simoes-Costa; Estefania Sánchez-Vásquez; Marianne E Bronner
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-01       Impact factor: 11.205

Review 4.  Neuroblastoma: molecular pathogenesis and therapy.

Authors:  Chrystal U Louis; Jason M Shohet
Journal:  Annu Rev Med       Date:  2014-10-27       Impact factor: 13.739

Review 5.  Specifying neural crest cells: From chromatin to morphogens and factors in between.

Authors:  Crystal D Rogers; Shuyi Nie
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2018-05-03       Impact factor: 5.814

6.  G-CSF receptor positive neuroblastoma subpopulations are enriched in chemotherapy-resistant or relapsed tumors and are highly tumorigenic.

Authors:  Danielle M Hsu; Saurabh Agarwal; Ashley Benham; Cristian Coarfa; Denae N Trahan; Zaowen Chen; Paris N Stowers; Amy N Courtney; Anna Lakoma; Eveline Barbieri; Leonid S Metelitsa; Preethi Gunaratne; Eugene S Kim; Jason M Shohet
Journal:  Cancer Res       Date:  2013-05-16       Impact factor: 12.701

7.  Formation of a Neurosensory Organ by Epithelial Cell Slithering.

Authors:  Christin S Kuo; Mark A Krasnow
Journal:  Cell       Date:  2015-10-01       Impact factor: 41.582

8.  PKCα Inhibition as a Strategy to Sensitize Neuroblastoma Stem Cells to Etoposide by Stimulating Ferroptosis.

Authors:  Lorenzo Monteleone; Andrea Speciale; Giulia Elda Valenti; Nicola Traverso; Silvia Ravera; Ombretta Garbarino; Riccardo Leardi; Emanuele Farinini; Antonella Roveri; Fulvio Ursini; Claudia Cantoni; Maria Adelaide Pronzato; Umberto Maria Marinari; Barbara Marengo; Cinzia Domenicotti
Journal:  Antioxidants (Basel)       Date:  2021-04-28

9.  A PHD12-Snail2 repressive complex epigenetically mediates neural crest epithelial-to-mesenchymal transition.

Authors:  Pablo H Strobl-Mazzulla; Marianne E Bronner
Journal:  J Cell Biol       Date:  2012-09-17       Impact factor: 10.539

10.  Stemness and inducing differentiation of small cell lung cancer NCI-H446 cells.

Authors:  Z Zhang; Y Zhou; H Qian; G Shao; X Lu; Q Chen; X Sun; D Chen; R Yin; H Zhu; Q Shao; W Xu
Journal:  Cell Death Dis       Date:  2013-05-16       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.